Excerpt
AIDS activists have criticized drug companies for the high cost of medications. World Trade Organization patent rules limit the manufacture of cheaper generic drugs, but efforts are being made to delay the rules in developing nations.
In This Issue
-
Foreword
Read More -
Evolution of an Epidemic
Two Decades of HIV/AIDS
Read More -
Global AIDS Overview
Current Trends and Progress Toward Containment
Read More -
Care of People With HIV/AIDS
Treatment and Support Services
Read More -
Patents and HIV/AIDS Drugs
Access and Affordability Issues
Read More -
Accelerating Access Initiative
A UN-Pharmaceutical Industry Partnership
Read More -
World Trade Organization Agreement
Intellectual Property Rights and Pharmaceuticals
Read More
Pro & Con
Are International Pharmaceutical Companies Doing Enough to Provide Low-Cost AIDS Drugs to Developing Countries?
